📄 medicine
The COVID-19 RNA vaccine SpikevaxTM transfects human umbilical endothelial cells and induces Spike protein production, inflammation and leukocyte adhesion
This study demonstrates that the COVID-19 RNA vaccine Spikevax™ transfects human umbilical endothelial cells to produce Spike protein, which subsequently triggers the expression of proinflammatory cytokines and adhesion molecules, leading to increased leukocyte adhesion without compromising cell viability.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.